Although further researches are needed to uncover the role of these structures for effect on immunotherapeutic outcomes and tumor-specific CD8+ T cell function, it can be inferred that TLSs and APC niches are predictive markers of immune checkpoint blockade (ICB). Here, CD8A is linked to neoplasm.